Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AISAT

Financiado

Cerrado

Development of a new high throughput automated imaging system to carry out drug...

Development of a new high throughput automated imaging system to carry out drug sensitivity measurements on primary leukemia lymphoma cells to assist individualized assay guided therapy The aim of the project is to build a new robust prototype of a high throughput automated imaging system that can be used in routine clinical lab environment for gathering data on drug sensitivity patterns of primary leukemia/lymph... ver más

30/06/2011

178K€

Presupuesto del proyecto: 178K€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2011-06-30 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

0.00€ | Lider

Proyectos interesantes

EQC2021-007516-P

Medical Technol...

Data Science

654K€ Cerrado

POC-TDM

Medical Technol...

Data Science

158K€ Cerrado

Oncosmart

Medical Technol...

Data Science

71K€ Cerrado

msGUIDE

Medical Technol...

Data Science

4M€ Cerrado

BONAFIDE PLATAFORMA DE ANÁLISIS HUESO EN CHI...

Medical Technol...

Data Science

431K€ Cerrado

SYNEBIO

Medical Technol...

Data Science

150K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 178K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The aim of the project is to build a new robust prototype of a high throughput automated imaging system that can be used in routine clinical lab environment for gathering data on drug sensitivity patterns of primary leukemia/lymphoma cells. The device will assist individualized assay guided therapy. The laboratory at the host institute has recently created a new microculture system that allows viability testing of drug treated primary tumor cells. The present system is exclusively based on commercially available components. It is also very complex and expensive. The primary data gathered on this system however appears to be so valuable that it warrants the development of a new, simpler, but highly parallelized device with a six fold increase in the work capacity for one twentieth of the price. The device will promote both basic research and improve adequate patient care. There is a long going and very fruitful collaboration between the host laboratory at the Karolinska institute and the home laboratory of the applicant that among other led to the development of novel surface plasmon resonance methods to study protein-protein interactions. The knowledge and experience of the applicant together with the preliminary development that has already taken place at the accepting institute provides a solid foundation for likely success. The applicant will also participate in a formal doctoral training in tumor biology and will contribute to the expansion of the imaging core facility of the Karolinska Institute.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores